TAG

Results for: research

In Press: Vedolizumab may have a real-life corticosteroid sparing effect

Vedolizumab may have a corticosteroid sparing effect in real-world clinical practice, a new Finnish study reveals. The incidence of inflammatory bowel disease (IBD), which include ulcerative colitis (UC) and Crohn’s disease (CD), is increasing worldwide. Accumulating data from clinical trials and real-world studies has demonstrated that vedolizumab, an anti-integrin antibody, is an effective and well-tolerated… Read more »


BC Platforms and MedEngine Announce a Strategic Partnership to Launch New Models for Global Medical Data Science Services

MedEngine Oy, a company specialized in high-quality medical data science services, and BC Platforms AG, a world leader in genomic data management and analytics, today announce a major strategic alliance to create turnkey research solutions for the pharmaceutical and health sectors. The first-of-a-kind partnership brings together BC Platform’s global network of biobanks and MedEngine’s expertise… Read more »


Finland has major competitive advantages for RWE research shows recent study conducted by MedEngine

Finland is in a good position to begin building a globally competitive ecosystem for real-world data (RWD) research, a qualitative survey conducted by MedEngine reveals. The survey was requested by the Pharma Industry Research Foundation and the results were presented at the Pharma Industry Finland Autumn meeting on November 21st, 2018. Real-world data and real-world… Read more »


MedEngine presented novel IBD and lung cancer data at the ISPOR congress in Barcelona

The 21st Annual European Congress of The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is currently (Nov 10–14th 2018) underway in Barcelona, Spain. This conference, titled “New Perspectives for Improving 21st Century Health Systems”, has attracted over 3,700 professionals from all health care sectors. Attendees are learning about recent trends in health economics and outcomes research… Read more »


In Press: Recording of Smoking Status Prior to Surgical Operation

A report published last week in Suomen Lääkärilehti (Finnish Medical Journal) investigated recording of preoperative smoking status in the Porvoo hospital area during the early implementation phase of the smoke-free surgery treatment model. The study demonstrated that recording of smoking status prior to elective surgery was not systematic: among 149 patients, smoking status was recorded at… Read more »


MedEngine ja DRA Consulting yhteistyöhön Market Access -palveluissa: tutkimustietoa ja strategista osaamista liiketoiminnan moottoriksi

Suomalaiset lääkealan asiantuntijapalveluihin erikoistuneet DRA Consulting Oy ja MedEngine Oy ovat aloittaneet Pohjoismaat kattavan yhteistyön. Yritysten keskeisenä tavoitteena on kehittää entistä tehokkaampia Market Access -palveluita yhdistämällä tosielämän tutkimustietoa strategiseen Market Access -osaamiseen.  MedEngine Oy:n ydinosaamista ovat rekisteritutkimukset (ns. real-world data) sekä Medical Affairs – ja markkinointipalvelut. DRA Consulting Oy on erikoistunut Market Access -palveluihin sekä… Read more »


In Press: Real-world treatment outcomes of vedolizumab among Finnish IBD patients (FINVEDO)

A recently published real-world cohort study demonstrated that vedolizumab, an anti-integrin antibody, is an effective and well-tolerated treatment option for patients with inflammatory bowel disease (IBD).  The FINVEDO study showed high treatment persistence and improvements in disease activity, even in the case of refractory disease, for IBD patients treated with vedolizumab. To date, approximately 50,000… Read more »


MedEngine presented results from three new studies at the ISPOR congress in Glasgow

The 20th Annual European Congress of The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) was held in Glasgow, Scotland on Nov 4–8th 2017. The event attracted nearly 5000 participants from 77 countries and across all health care sectors. MedEngine participated in the congress, and presented results from three new real-world data research projects. ISPOR… Read more »


Beyond treating patients: Secondary uses of health and social data

Whether it be an encounter with a physician or nurse, a prescription for medication from a pharmacy, or admittance of a student loan—every contact that we have with health care personnel or the social security system generates data related to our health and well-being. Currently, the Finnish Ministry of Social Affairs and Health is preparing… Read more »


MedEngine presented the first results from the HemoHEOR study at the NordCoag 2017 meeting

The largest coagulation disorders meeting of the Nordic Countries, The 50th Nordic Coagulation Meeting, was organized in Helsinki last week. At the meeting, MedEngine presented the first results from its unique nationwide real world data cohort HemoHEOR. Hemophilia is a chronic congenital bleeding disorder, caused by a deficiency of coagulation factor VIII (FVIII) in hemophilia A… Read more »


CONTACT

MEDENGINE - BRIDGING
MEDICAL SCIENCE
WITH BUSINESS

GET IN TOUCH

029-1701101
info@medengine.fi

VISIT US

Eteläranta 14
00130 Helsinki
FINLAND


© 2019 MedEngine Oy